The enteral nutrition containing slow release starch improves the outcome of severe acute pancreatitis patients

Objective: To evaluate the impacts of enteral nutrition contained with slow release starch in severe acute pancreatitis(SAP) patients. Methods: 180 cases of SAP patients were randomly divided into slow release starch group(Fresubin diabetes,SSPC,n=90) and control group(Fresubin,SSPC,n=90).The fasting blood glucose(FBG),2-hour postprandial blood glucose(2h BG) and glycosylated hemoglobin(HbA1c) were examined at base line and 10 days after nutrition support.The infectious rates,complication rates,mortality and hospital stay were compared between the two groups.Results: FBG,2h BG and HbA1c were significantly lower in slow release starch group than control group(P0.05)10 days after nutrition treatment.The infectious rate and complication rate were also significantly lower compared with control group(P0.05).The mortality rate was not significantly different between the two groups(P0.05),and the hospital stay in slow release starch group was shorter than control group(P0.05).Conclusion: Enteral nutrition contained with slow release starch is the preferred enteral nutrition in severe acute pancreatitis(SAP) patients.